Drug · DIN 02014068

CLINIMIX E

5% AMINO ACIDS (BLEND B) WITH ELECTROLYTES IN 20% DEXTROSE INJECTION

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since March 25, 2021; first marketed December 31, 1994.

Active ingredients

As listed in the Drug Product Database.

Ingredient	Strength	Per
SODIUM CHLORIDE	58.5 MG	100 ML
MAGNESIUM CHLORIDE	24 MG	100 ML
DEXTROSE	20 G	100 ML
L-LEUCINE HYDROCHLORIDE	310 MG	100 ML
L-PHENYLALANINE HYDROCHLORIDE	310 MG	100 ML
L-LYSINE HYDROCHLORIDE	290 MG	100 ML
METHIONINE	290 MG	100 ML
L-ALANINE	1.04 G	100 ML
GLYCINE	1.04 G	100 ML
L-ARGININE	520 MG	100 ML
L-ISOLEUCINE	240 MG	100 ML
L-VALINE	230 MG	100 ML
HISTIDINE	220 MG	100 ML
L-THREONINE	210 MG	100 ML
TRYPTOPHAN	90 MG	100 ML
L-PROLINE	210 MG	100 ML
L-TYROSINE	20 MG	100 ML
SODIUM ACETATE	205 MG	100 ML
POTASSIUM PHOSPHATE DIBASIC	261 MG	100 ML

Health Canada approvals that name this DIN.

October 31, 2013: NOC 14869New Drug Submission (NDS) · Manufacturer and product name change
October 17, 2003: NOC 435Supplement to a New Drug Submission (SNDS) · Product name change from travasol amino acid injection with electrolytes in dextrose quickmix